Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

6.38USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$6.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
222,597
52-wk High
$22.00
52-wk Low
$6.28

Chart for

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 2.29
Market Cap(Mil.): $713.08
Shares Outstanding(Mil.): 40.29
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.60 -- --
ROI: -29.33 8.92 14.45
ROE: -30.75 10.08 15.96

Earnings vs. Estimates